Platelets in Thrombosis and Atherosclerosis A Double-Edged Sword

被引:7
作者
Bravo, Gabriela Martinez [1 ]
Annarapu, Gowtham [5 ]
Carmona, Emely [6 ]
Nawarskas, James [2 ]
Clark, Ross [3 ,4 ]
Novelli, Enrico [5 ,6 ]
Alvidrez, Roberto I. Mota [1 ,2 ,4 ]
机构
[1] Univ New Mexico, Biomed Engn Dept, Albuquerque, NM USA
[2] Univ New Mexico, Pharmaceut Sci Pharm Practice, Albuquerque, NM USA
[3] Univ New Mexico, Coll Pharm Cell Biol & Physiol, Albuquerque, NM USA
[4] Univ New Mexico, Clin & Translat Sci Ctr, Albuquerque, NM USA
[5] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh, PA USA
关键词
ACUTE CORONARY SYNDROMES; VON-WILLEBRAND-FACTOR; TISSUE FACTOR; P-SELECTIN; INFLAMMATION; MECHANISMS; RECEPTOR; INHIBITION; HEMOSTASIS; DISEASE;
D O I
10.1016/j.ajpath.2024.05.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This review focuses on the dual role of platelets in atherosclerosis and thrombosis, exploring their involvement in inflammation, angiogenesis, and plaque formation, as well as their hemostatic and pro- thrombotic functions. Beyond their thrombotic functions, platelets engage in complex interactions with diverse cell types, influencing disease resolution and progression. The contribution of platelet degranulation helps in the formation of atheromatous plaque, whereas the reciprocal interaction with monocytes adds complexity. Alterations in platelet membrane receptors and signaling cascades contribute to advanced atherosclerosis, culminating in atherothrombotic events. Understanding these multifaceted roles of platelets will lead to the development of targeted antiplatelet strategies for effective cardiovascular disease prevention and treatment. Understanding platelet functions in atherosclerosis and atherothrombosis at different stages of disease will be critical for designing targeted treatments and medications to prevent or cure the disease Through this understanding, platelets can be targeted at specific times in the atherosclerosis process, possibly preventing the development of atherothrombosis.
引用
收藏
页码:1608 / 1621
页数:14
相关论文
共 110 条
  • [91] Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention
    Steinhubl, SR
    Kottke-Marchant, K
    Moliterno, DJ
    Rosenthal, ML
    Godfrey, NK
    Coller, BS
    Topol, EJ
    Lincoff, AM
    [J]. CIRCULATION, 1999, 100 (19) : 1977 - 1982
  • [92] Monocyte-Macrophages and T Cells in Atherosclerosis
    Tabas, Ira
    Lichtman, Andrew H.
    [J]. IMMUNITY, 2017, 47 (04) : 621 - 634
  • [93] Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile of the Oral Antiplatelet Agent Ticagrelor
    Teng, Renli
    [J]. CLINICAL PHARMACOKINETICS, 2012, 51 (05) : 305 - 318
  • [94] High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol
    Trajkovska, Katerina Tosheska
    Topuzovska, Sonja
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (02) : 149 - 154
  • [95] Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
    Tsao, Connie W.
    Aday, Aaron W.
    Almarzooq, Zaid I.
    Anderson, Cheryl A. M.
    Arora, Pankaj
    Avery, Christy L.
    Baker-Smith, Carissa M.
    Beaton, Andrea Z.
    Boehme, Amelia K.
    Buxton, Alfred E.
    Commodore-Mensah, Yvonne
    Elkind, Mitchell S. V.
    Evenson, Kelly R.
    Eze-Nliam, Chete
    Fugar, Setri
    Generoso, Giuliano
    Heard, Debra G.
    Hiremath, Swapnil
    Ho, Jennifer E.
    Kalani, Rizwan
    Kazi, Dhruv S.
    Ko, Darae
    Levine, Deborah A.
    Liu, Junxiu
    Ma, Jun
    Magnani, Jared W.
    Michos, Erin D.
    Mussolino, Michael E.
    Navaneethan, Sankar D.
    Parikh, Nisha I.
    Poudel, Remy
    Rezk-Hanna, Mary
    Roth, Gregory A.
    Shah, Nilay S.
    St-Onge, Marie-Pierre
    Thacker, Evan L.
    Virani, Salim S.
    Voeks, Jenifer H.
    Wang, Nae-Yuh
    Wong, Nathan D.
    Wong, Sally S.
    Yaffe, Kristine
    Martin, Seth S.
    [J]. CIRCULATION, 2023, 147 (08) : E93 - E621
  • [96] Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
    Undas, Anetta
    Brummel-Ziedins, Kathleen E.
    Mann, Kenneth G.
    [J]. BLOOD, 2007, 109 (06) : 2285 - 2292
  • [97] Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI
    Valiyaveettil, Manojkumar
    Kar, Niladri
    Ashraf, Mohammad Z.
    Byzova, Tatiana V.
    Febbraio, Maria
    Podrez, Eugene A.
    [J]. BLOOD, 2008, 111 (04) : 1962 - 1971
  • [98] How leukocytes cross the vascular endothelium
    Vestweber, Dietmar
    [J]. NATURE REVIEWS IMMUNOLOGY, 2015, 15 (11) : 692 - 704
  • [99] Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase
    Viswambharan, H
    Ming, XF
    Zhu, SS
    Hubsch, A
    Lerch, P
    Vergères, G
    Rusconi, S
    Yang, ZH
    [J]. CIRCULATION RESEARCH, 2004, 94 (07) : 918 - 925
  • [100] Platelets as immune cells - Bridging inflammation and cardiovascular disease
    von Hundelshausen, Philipp
    Weber, Christian
    [J]. CIRCULATION RESEARCH, 2007, 100 (01) : 27 - 40